Skip to content

Medical emergency? What to do

Consumer group says Celebrex ad downplays risks

3-RXPublished April 11, 20073 min read

Key points

  • A consumer group accused Pfizer Inc. on Monday of downplaying safety differences between its Celebrex medicine and other painkillers in a new advertisement and said U.S. regulators should ask that the ad be pulled.
  • Celebrex and Vioxx are both so-called COX-2 inhibitors, drugs billed as gentler on the stomach than painkillers like naproxen and ibuprofen, which are cheaper and available without a prescription.
  • The consumer group Public Citizen in a letter to the U.S.
  • The ad may lead consumers to opt for more expensive, riskier Celebrex over "equally effective safer alternatives such as (over-the-counter) naproxen."

A consumer group accused Pfizer Inc. on Monday of downplaying safety differences between its Celebrex medicine and other painkillers in a new advertisement and said U.S. regulators should ask that the ad be pulled.

Pfizer, the world's biggest drugmaker, began running television spots for Celebrex last week, after a more than two-year hiatus. Pfizer had stopped advertising for the arthritis drug after Merck & Co. Inc.'s rival drug Vioxx was withdrawn from the market. Vioxx was linked to an elevated risk of heart attack and stroke in long-term users.

Celebrex and Vioxx are both so-called COX-2 inhibitors, drugs billed as gentler on the stomach than painkillers like naproxen and ibuprofen, which are cheaper and available without a prescription. But the withdrawal of Vioxx and a similar Pfizer drug called Bextra put the class under a serious safety shadow, and sales plunged.

The COX-2 inhibitors and drugs like naproxen and ibuprofen are in a broader class of drugs, called NSAIDs, or non-steroidal anti-inflammatory drugs.

The consumer group Public Citizen in a letter to the U.S. Food and Drug Administration argued that the ad tries to lump all drugs in the NSAID class together in terms of heart risks, when there are clear differences.

"The overall purpose of the ad is to make it appear, contrary to scientific evidence, that the cardiovascular dangers of Celebrex are not greater than" others, Sidney Wolfe, director of the health group at Public Citizen, wrote.

The ad may lead consumers to opt for more expensive, riskier Celebrex over "equally effective safer alternatives such as (over-the-counter) naproxen."

A spokeswoman for the FDA was not available for comment. Pfizer said it will not pull the ad and defended its accuracy.

The withdrawal of Vioxx also led to increased public scrutiny of the role of pharmaceutical advertising, amid claims that the heavy promotion of Vioxx led to overuse.

After the Vioxx withdrawal, the FDA required all medicines in the NSAID class to carry so-called "black box" warnings, noting they pose a risk of serious heart-related problems, including heart attacks and stroke.

The Pfizer ad states that heart risks for naproxen and ibuprofen are not clear, but Public Citizen cites a review by the British Medical Journal last year finding naproxen poses no increased risk of dangerous side effects on the heart.

Pfizer senior medical director Gail Cawkwell said the medical journal study was not definitive because it was a so-called meta-analysis - a review of many studies. She also cited another clinical trial, which found an increased risk with naproxen.

The Celebrex advertisement also states that the FDA requires all NSAIDs to carry the same heart risk warning, which Public Citizen said is misleading.

The American Heart Association, for example, has stated that there are clear risk differences between the painkillers and recommends that patients with heart ailments start on naproxen, with the COX-2 drugs the last choice.

"What we are trying to convey through the ad is that all prescription NSAIDs carry the same warnings. A warning is different than a risk," Cawkwell said.

Public Citizen also called the ad misleading because it says that Celebrex carries lower rates of abdominal pain and nausea than other drugs. Public Citizen says this claim obscures the fact that all drugs in the class carry a risk of much more serious stomach problems, like bleeding and ulcers.

Pfizer's Cawkwell said Pfizer's claims are backed by the FDA-approved label.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underDrug News

Keep reading

Cancer

Avastin Slows Resistant Ovarian Cancer

Progression of platinum-resistant ovarian cancer slowed by more than 50% in patients who received bevacizumab (Avastin) plus chemotherapy compared with nonplatinum chemotherapy alone, results of a randomized trial…

3 min read

Drug News

Prevnar trial results needed for CDC recommendation

Advisors to the U.S. Centers for Disease Control and Prevention on Wednesday will wait for results from a trial of Pfizer Inc's Prevnar 13 pneumonia vaccine before deciding whether to recommend its use in all adults…

1 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.